Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
Schmook
T
T
Kraft
J
J
Benninghoff
B
B
Nindl
I
I
Roewert
J
J
Ulrich
C
C
Stockfleth
E
E
D000287:Administration, Topical; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D003879:Dermatologic Agents; C117268:pimecrolimus; D016559:Tacrolimus